O	0	3	The	The	DT	B-NP
B-Cell	4	10	neural	neural	JJ	I-NP
I-Cell	11	15	stem	stem	NN	I-NP
I-Cell	16	20	cell	cell	NN	I-NP
O	21	25	fate	fate	NN	I-NP
O	26	37	determinant	determinant	JJ	I-NP
O	38	41	TLX	TLX	NN	I-NP
O	42	50	promotes	promote	VBZ	B-VP
O	51	64	tumorigenesis	tumorigenesis	NN	B-NP
O	65	68	and	and	CC	I-NP
O	69	76	genesis	genesis	NN	I-NP
O	77	79	of	of	IN	B-PP
B-Cell	80	85	cells	cell	NNS	B-NP
O	86	96	resembling	resemble	VBG	B-VP
B-Cell	97	103	glioma	glioma	NN	B-NP
I-Cell	104	108	stem	stem	NN	I-NP
I-Cell	109	114	cells	cell	NNS	I-NP
O	114	115	.	.	.	O

O	117	118	A	A	DT	B-NP
O	119	126	growing	grow	VBG	I-NP
B-Organism_subdivision	127	131	body	body	NN	I-NP
O	132	134	of	of	IN	B-PP
O	135	143	evidence	evidence	NN	B-NP
O	144	153	indicates	indicate	VBZ	B-VP
O	154	158	that	that	IN	B-SBAR
O	159	171	deregulation	deregulation	NN	B-NP
O	172	174	of	of	IN	B-PP
B-Cell	175	179	stem	stem	NN	B-NP
I-Cell	180	184	cell	cell	NN	I-NP
O	185	189	fate	fate	NN	I-NP
O	190	202	determinants	determinant	NNS	I-NP
O	203	205	is	be	VBZ	B-VP
O	206	207	a	a	DT	B-NP
O	208	216	hallmark	hallmark	NN	I-NP
O	217	219	of	of	IN	B-PP
O	220	224	many	many	JJ	B-NP
O	225	230	types	type	NNS	I-NP
O	231	233	of	of	IN	B-PP
B-Cancer	234	246	malignancies	malignancy	NNS	B-NP
O	246	247	.	.	.	O

O	248	251	The	The	DT	B-NP
B-Cell	252	258	neural	neural	JJ	I-NP
I-Cell	259	263	stem	stem	NN	I-NP
I-Cell	264	268	cell	cell	NN	I-NP
O	269	273	fate	fate	NN	I-NP
O	274	285	determinant	determinant	JJ	I-NP
O	286	289	TLX	TLX	NN	I-NP
O	290	295	plays	play	VBZ	B-VP
O	296	297	a	a	DT	B-NP
O	298	305	pivotal	pivotal	JJ	I-NP
O	306	310	role	role	NN	I-NP
O	311	313	in	in	IN	B-PP
O	314	326	neurogenesis	neurogenesis	NN	B-NP
O	327	329	in	in	IN	B-PP
O	330	333	the	the	DT	B-NP
O	334	339	adult	adult	JJ	I-NP
B-Organ	340	345	brain	brain	NN	I-NP
O	346	348	by	by	IN	B-PP
O	349	360	maintaining	maintain	VBG	B-VP
B-Cell	361	367	neural	neural	JJ	B-NP
I-Cell	368	372	stem	stem	NN	I-NP
I-Cell	373	378	cells	cell	NNS	I-NP
O	378	379	.	.	.	O

O	380	384	Here	Here	RB	B-ADVP
O	384	385	,	,	,	O
O	386	388	we	we	PRP	B-NP
O	389	395	report	report	VBP	B-VP
O	396	397	a	a	DT	B-NP
O	398	409	tumorigenic	tumorigenic	JJ	I-NP
O	410	414	role	role	NN	I-NP
O	415	417	of	of	IN	B-PP
O	418	421	TLX	TLX	NN	B-NP
O	422	424	in	in	IN	B-PP
B-Cancer	425	430	brain	brain	NN	B-NP
I-Cancer	431	436	tumor	tumor	NN	I-NP
O	437	447	initiation	initiation	NN	I-NP
O	448	451	and	and	CC	I-NP
O	452	463	progression	progression	NN	I-NP
O	463	464	.	.	.	O

O	465	474	Increased	Increase	VBN	B-NP
O	475	478	TLX	TLX	NN	I-NP
O	479	489	expression	expression	NN	I-NP
O	490	493	was	be	VBD	B-VP
O	494	502	observed	observe	VBN	I-VP
O	503	505	in	in	IN	B-PP
O	506	507	a	a	DT	B-NP
O	508	514	number	number	NN	I-NP
O	515	517	of	of	IN	B-PP
B-Cell	518	524	glioma	glioma	NN	B-NP
I-Cell	525	530	cells	cell	NNS	I-NP
O	531	534	and	and	CC	O
B-Cell	535	541	glioma	glioma	NN	B-NP
I-Cell	542	546	stem	stem	NN	I-NP
I-Cell	547	552	cells	cell	NNS	I-NP
O	552	553	,	,	,	O
O	554	557	and	and	CC	O
O	558	568	correlated	correlate	VBD	B-VP
O	569	573	with	with	IN	B-PP
O	574	578	poor	poor	JJ	B-NP
O	579	587	survival	survival	NN	I-NP
O	588	590	of	of	IN	B-PP
O	591	599	patients	patient	NNS	B-NP
O	600	604	with	with	IN	B-PP
B-Cancer	605	612	gliomas	glioma	NNS	B-NP
O	612	613	.	.	.	O

O	614	621	Ectopic	Ectopic	JJ	B-NP
O	622	632	expression	expression	NN	I-NP
O	633	635	of	of	IN	B-PP
O	636	639	TLX	TLX	NN	B-NP
O	640	642	in	in	IN	B-PP
O	643	646	the	the	DT	B-NP
B-Cell	647	652	U87MG	U87MG	NN	I-NP
I-Cell	653	659	glioma	glioma	NN	I-NP
I-Cell	660	664	cell	cell	NN	I-NP
I-Cell	665	669	line	line	NN	I-NP
O	670	673	and	and	CC	O
B-Cell	674	679	Ink4a	Ink4a	NN	B-NP
I-Cell	679	680	/	/	SYM	B-NP
I-Cell	680	683	Arf	Arf	NN	I-NP
I-Cell	683	684	-	-	HYPH	B-NP
I-Cell	684	693	deficient	deficient	JJ	I-NP
I-Cell	694	699	mouse	mouse	NN	I-NP
I-Cell	700	710	astrocytes	astrocyte	NNS	I-NP
O	711	712	(	(	(	O
B-Cell	712	717	Ink4a	Ink4a	NN	B-NP
I-Cell	717	718	/	/	SYM	O
I-Cell	718	721	Arf	Arf	NN	B-NP
I-Cell	721	722	(	(	(	O
I-Cell	722	723	-	-	SYM	O
I-Cell	723	724	/	/	SYM	O
I-Cell	724	725	-	-	SYM	O
I-Cell	725	726	)	)	)	O
I-Cell	727	737	astrocytes	astrocyte	NNS	B-NP
O	737	738	)	)	)	O
O	739	746	induced	induce	VBN	B-NP
B-Cell	747	751	cell	cell	NN	I-NP
O	752	765	proliferation	proliferation	NN	I-NP
O	766	770	with	with	IN	B-PP
O	771	772	a	a	DT	B-NP
O	773	784	concomitant	concomitant	JJ	I-NP
O	785	793	increase	increase	NN	I-NP
O	794	796	in	in	IN	B-PP
O	797	803	cyclin	cyclin	NN	B-NP
O	804	805	D	D	NN	I-NP
O	806	816	expression	expression	NN	I-NP
O	816	817	,	,	,	O
O	818	821	and	and	CC	O
O	822	833	accelerated	accelerate	VBD	B-VP
B-Cell	834	838	foci	focus	NNS	B-NP
O	839	848	formation	formation	NN	I-NP
O	849	851	in	in	IN	B-PP
O	852	856	soft	soft	JJ	B-NP
O	857	861	agar	agar	NN	I-NP
O	862	865	and	and	CC	I-NP
B-Cancer	866	871	tumor	tumor	NN	I-NP
O	872	881	formation	formation	NN	I-NP
O	882	884	in	in	IN	B-PP
O	885	887	in	in	FW	B-NP
O	888	892	vivo	vivo	FW	I-NP
O	893	908	transplantation	transplantation	NN	I-NP
O	909	915	assays	assay	NNS	I-NP
O	915	916	.	.	.	O

O	917	928	Furthermore	Furthermore	RB	B-ADVP
O	928	929	,	,	,	O
O	930	944	overexpression	overexpression	NN	B-NP
O	945	947	of	of	IN	B-PP
O	948	951	TLX	TLX	NN	B-NP
O	952	954	in	in	IN	B-PP
B-Cell	955	960	Ink4a	Ink4a	NN	B-NP
I-Cell	960	961	/	/	SYM	B-NP
I-Cell	961	964	Arf	Arf	NN	I-NP
I-Cell	964	965	(	(	(	O
I-Cell	965	966	-	-	SYM	O
I-Cell	966	967	/	/	SYM	O
I-Cell	967	968	-	-	SYM	O
I-Cell	968	969	)	)	)	O
I-Cell	970	980	astrocytes	astrocyte	NNS	B-NP
O	981	990	inhibited	inhibit	VBD	B-VP
B-Cell	991	995	cell	cell	NN	B-NP
O	996	1005	migration	migration	NN	I-NP
O	1006	1009	and	and	CC	I-NP
O	1010	1018	invasion	invasion	NN	I-NP
O	1019	1022	and	and	CC	O
O	1023	1031	promoted	promote	VBD	B-VP
B-Cell	1032	1043	neurosphere	neurosphere	NN	B-NP
O	1044	1053	formation	formation	NN	I-NP
O	1054	1057	and	and	CC	O
O	1058	1064	Nestin	Nestin	NN	B-NP
O	1065	1075	expression	expression	NN	I-NP
O	1075	1076	,	,	,	O
O	1077	1082	which	which	WDT	B-NP
O	1083	1086	are	be	VBP	B-VP
O	1087	1095	hallmark	hallmark	JJ	B-NP
O	1096	1111	characteristics	characteristic	NNS	I-NP
O	1112	1114	of	of	IN	B-PP
B-Cell	1115	1121	glioma	glioma	NN	B-NP
I-Cell	1122	1126	stem	stem	NN	I-NP
I-Cell	1127	1132	cells	cell	NNS	I-NP
O	1132	1133	,	,	,	O
O	1134	1139	under	under	IN	B-PP
B-Cell	1140	1144	stem	stem	NN	B-NP
I-Cell	1145	1149	cell	cell	NN	I-NP
O	1150	1157	culture	culture	NN	I-NP
O	1158	1168	conditions	condition	NNS	I-NP
O	1168	1169	.	.	.	O

O	1170	1173	Our	Our	PRP$	B-NP
O	1174	1181	results	result	NNS	I-NP
O	1182	1190	indicate	indicate	VBP	B-VP
O	1191	1195	that	that	IN	B-SBAR
O	1196	1199	TLX	TLX	NN	B-NP
O	1200	1202	is	be	VBZ	B-VP
O	1203	1211	involved	involve	VBN	I-VP
O	1212	1214	in	in	IN	B-PP
B-Cell	1215	1221	glioma	glioma	NN	B-NP
I-Cell	1222	1226	stem	stem	NN	I-NP
I-Cell	1227	1231	cell	cell	NN	I-NP
O	1232	1239	genesis	genesis	NN	I-NP
O	1240	1243	and	and	CC	O
O	1244	1254	represents	represent	VBZ	B-VP
O	1255	1256	a	a	DT	B-NP
O	1257	1266	potential	potential	JJ	I-NP
O	1267	1278	therapeutic	therapeutic	JJ	I-NP
O	1279	1285	target	target	NN	I-NP
O	1286	1289	for	for	IN	B-PP
O	1290	1294	this	this	DT	B-NP
O	1295	1299	type	type	NN	I-NP
O	1300	1302	of	of	IN	B-PP
B-Cancer	1303	1313	malignancy	malignancy	NN	B-NP
O	1313	1314	.	.	.	O

